Legacy Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
+193
New +$197K 0.16% 50
2025
Q4
Sell
-265
Closed -$202K 51
2025
Q3
$202K Buy
+265
New +$197K 0.15% 50
2025
Q2
Sell
-538
Closed -$444K 48
2025
Q1
$444K Buy
538
+23
+4% +$19.1K 0.38% 31
2024
Q4
$398K Buy
515
+134
+35% +$111K 0.34% 39
2024
Q3
$338K Buy
+381
New +$343K 0.29% 44

Other funds holding LLY

Legacy Advisory Services's LLY Position: Q2 2026 in Review

Legacy Advisory Services opened a new position in Eli Lilly (LLY) in Q2 2026: 193 shares worth $232K. The stake represents 0.16% of the portfolio and ranks #50 among its holdings. This is a return to the name: Legacy Advisory Services previously reported a position in LLY as recently as Q3 2025.

Legacy Advisory Services first reported a position in LLY in Q3 2024 and has held it in 5 quarters since. The position peaked at $444K in Q1 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Advisory Services held 193 shares of Eli Lilly worth $232K as of Q2 2026.
  • Eli Lilly was a new Legacy Advisory Services position in Q2 2026.
  • Eli Lilly made up 0.16% of Legacy Advisory Services's portfolio in Q2 2026, its #50 holding.
  • Legacy Advisory Services first reported a position in Eli Lilly in Q3 2024 and has held it in 5 quarters since.
  • Legacy Advisory Services's Eli Lilly position peaked at $444K in Q1 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Advisory Services's 13F filing for Q2 2026, filed 21 Jul 2026.